Loss of taste is a relatively common symptom of coronavirus disease 2019 (COVID-19) and has also been considered a rare Guillain-Barré syndrome (GBS) symptom. We herein report a case of a facial diplegia and paresthesia (FDP) variant of GBS that initially presented as a loss of taste occurring two weeks after COVID-19 mRNA vaccination. The patient recovered completely after intravenous immunoglobulin therapy. Clinicians should consider the possibility of post-vaccination FDP manifesting as facial palsy and should be aware that GBS, including the FDP variant, can initially present as an isolated loss of taste.
CITATION STYLE
Hiraga, A., Muto, M., & Kuwabara, S. (2022). Loss of Taste as an Initial Symptom of a “Facial Diplegia and Paresthesia” Variant of Guillain-Barré Syndrome. Internal Medicine, 61(19), 2957–2959. https://doi.org/10.2169/internalmedicine.9781-22
Mendeley helps you to discover research relevant for your work.